Neuland Laboratories

NEULANDLAB · NSE

— · —

₹17,345

Closing price — 19 Jun 2026

Market cap ₹22,365 Cr · EPS ₹13.06

Loading financial data for Neuland Laboratories…

Valuation

Blended fair value using DCF and peer comparison methods.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

Contract research & manufacturing · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
Neuland Laboratories NEULANDLAB · you	₹22,365 Cr	61.5×	11.9×	39.2×	19.4%	18.0%	19.3%
Sector median	—	65.3×	5.5×	39.1×	13.5%	14.5%	10.8%
Laurus Labs LAURUSLABS	₹76,900 Cr	85.5×	14.3×	43.4×	16.8%	13.0%	4.1%
Anthem Biosciences ANTHEM	₹43,836 Cr	74.1×	14.3×	54.2×	19.5%	27.9%	26.2%
Sai Life Sciences SAILIFE	₹26,076 Cr	74.8×	10.5×	41.9×	14.0%	15.9%	21.7%
Granules India GRANULES	₹18,955 Cr	31.3×	3.7×	16.4×	11.7%	11.1%	5.9%
Syngene International SYNGENE	₹18,242 Cr	56.5×	3.7×	20.2×	6.5%	8.5%	5.4%
Caplin Point Laboratories CAPLIPOINT	₹17,160 Cr	25.1×	4.5×	22.6×	17.9%	29.3%	14.2%
Cohance Lifesciences COHANCE	₹16,515 Cr	92.3×	4.2×	41.7×	4.6%	7.9%	19.2%
Concord Biotech CONCORDBIO	₹13,302 Cr	51.3×	6.6×	36.5×	12.9%	24.7%	7.3%

Peer comparison verdict

Neuland is fairly valued relative to sector peers — trading near the sector median on key multiples (P/E ~65.3×, EV/EBITDA ~39.1×). Focus on execution quality and earnings trajectory from here.

Business quality

Key profitability, efficiency, and solvency metrics.

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Income statement data is loading…

Cash flow

Where cash comes from and where it goes.

Operating CFInvesting CFFinancing CFFree cash flow

Operating CF — Cash earned from running the business. The core engine of financial health.

Investing CF — Cash spent on assets and equipment. Negative is normal — it means the company is investing in growth.

Financing CF — Cash from borrowing or repaying loans and dividends. Negative means debt is being repaid.

Free cash flow — Operating CF minus capex. Cash left after keeping the business running. Positive and growing is ideal.

Operating CF

₹346.68 Cr

Investing CF

₹0 Cr

Financing CF

₹0 Cr

Free cash flow

-₹50.45 Cr

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

How the company is funded — equity is owners' money, debt is long-term borrowing, current liabilities are short-term obligations.

Equity

Debt

Current liabilities

Total assets

—

Total debt

₹161 Cr

Equity

₹1,874 Cr

Debt / Equity

0.09×

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.